Clinical Trials Browser

Interventional × saracatinib × Head & Neck × Clear all

NCT00513435 2014-04-30

Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Phase 2 Completed

9 enrolled 8 charts

Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms